Andrew P. Han - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Andrew P. Han's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Andrew P. Han
Verified
Staff Reporter, GenomeWeb
New York
Beats
pharmaceutical industry medicineBiotechnology healthcare
I am not a political news reporter.
Content
By Andrew P. Han Verified| Precision Medicine Online Verified NEW YORK – Memorial Sloan Kettering Cancer Center (MSK) is in the process of implementing a new rapid sequencing-based cancer panel to complement ongoing comprehensive genomic profiling (CGP). The assay, branded as MSK-React, is based on a new panel from Pillar Biosciences, recently launched as the OncoReveal Nexus. MSK-React masks two of the 21 genes in the panel and is available in separate reported formats for solid and hematological tumors.
By Andrew P. Han Verified| 360Dx Verified NEW YORK – Illumina said on Monday that it plans to divest Grail by June 2024 in either a third-party sale or a capital markets transaction. The announcement comes after the US Court of Appeals for the Fifth Circuit issued a decision on Friday that sidestepped Illumina's grandest arguments about why the US Federal Trade Commission erred in April when it ordered Illumina to sell off the multi-cancer early detection test company it bought in 2021 for approximately $8 billion.
By Andrew P. Han Verified| Precision Medicine Online Verified NEW YORK – Memorial Sloan Kettering Cancer Center (MSK) is in the process of implementing a new rapid sequencing-based cancer panel to complement ongoing comprehensive genomic profiling (CGP). The assay, branded as MSK-React, is based on a new panel from Pillar Biosciences, recently launched as the OncoReveal Nexus. MSK-React masks two of the 21 genes in the panel and is available in separate reported formats for solid and hematological tumors.
Company Info
GenomeWeb
GenomeWeb is an independent online news organization based in New York, established in 1997. It serves the global community of scientists, technology professionals, and executives involved in molecular biology research and molecular diagnostics. As a business unit of Crain Communications, GenomeWeb focuses on delivering comprehensive news coverage and in-depth analysis in the fields of genomics and molecular diagnostics. The organization operates the largest online newsroom dedicated to advanced molecular research tools, providing exclusive news and insights. Key offerings include detailed news and analysis of scientific advancements, premium content for subscribers, access to data centers and research reports, and newsletters to keep professionals updated on the latest developments. GenomeWeb's audience includes major scientific organizations, biopharmaceutical companies, research universities, and clinical labs, making it a vital resource in the genomics sector.
New York, New York, United States
+1 212-269-4747
Founded: 1997